(Q34661480)

English

Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

0 references

Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

0 references

0 references

vascular dementia

1 reference

based on heuristic

inferred from title

author name string

Harish Kavirajan

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Lon S Schneider

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

publication date

1 September 2007

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Lancet Neurology

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

782-792

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Epidemiology of vascular dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970195-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Vascular Dementia in a Population-Based Autopsy Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970195-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A population-based study of dementia in 85-year-olds.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970195-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970195-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A systematic review of the clinical effectiveness of donepezil, rivastigmine and galantamine on cognition, quality of life and adverse events in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970195-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The rationale behind cholinergic drug treatment for dementia related to cerebrovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970195-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Vascular determinants of cholinergic deficits in Alzheimer disease and vascular dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970195-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cholinesterase inhibitors: A new class of psychotropic compounds

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970195-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Memantine in vascular dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970195-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Galantamine for Alzheimer's disease and mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970195-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Donepezil for vascular cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970195-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Memantine for dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970195-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970195-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970195-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970195-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Donepezil in vascular dementia: a randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970195-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970195-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of memantine in patients with mild to moderate vascular dementia: a randomized, placebo-controlled trial (MMM 300).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970195-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970195-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cholinesterase inhibitors for vascular dementia?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970195-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Rivastigmine for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970195-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Donepezil for dementia due to Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970195-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Progress in clinical neurosciences: Canadian guidelines for the development of antidementia therapies: a conceptual summary.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970195-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Donepezil in vascular dementia: combined analysis of two large-scale clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970195-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of summary patient-level covariates in meta-regression with individual patient data meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970195-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1474-4422(07)70195-3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34661480&oldid=1977947440"